EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Microbix Biosystems's enterprise value is C$39.19 Mil.
Microbix Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was C$23.84 Mil. Therefore, Microbix Biosystems's EV-to-Revenue for today is 1.64.
The historical rank and industry rank for Microbix Biosystems's EV-to-Revenue or its related term are showing as below:
TSX:MBX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.61 Med: 3.17 Max: 9.38
Current: 1.64
During the past 13 years, the highest EV-to-Revenue of Microbix Biosystems was 9.38. The lowest was 1.61. And the median was 3.17.
TSX:MBX's EV-to-Revenue is ranked better than 81.82% of 1034
companies
in the Biotechnology industry
Industry Median: 7.93
vs TSX:MBX: 1.64
The historical data trend for Microbix Biosystems's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Microbix Biosystems's EV-to-Revenue
For the Biotechnology subindustry, Microbix Biosystems's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbix Biosystems's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Microbix Biosystems's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Microbix Biosystems's EV-to-Revenue falls into.
Microbix Biosystems's current Enterprise Value is C$39.19 Mil.
Microbix Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$23.84 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbix Biosystems's share price for today is C$0.33.
Microbix Biosystems's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.17.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbix Biosystems EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Microbix Biosystems's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Microbix Biosystems (TSX:MBX) Business Description
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:MBX has been successfully added to your 